Latest Market News

VRX Silica Limited has locked in six binding offtake contracts totaling nearly 1 million tonnes per annum and appointed a new CEO, marking significant progress for its Arrowsmith North silica sand project.

Genetic Signatures reported a $3.3 million quarterly revenue with growing international sales and a robust cash position, while preparing for a leadership change.

Tungsten Mining NL advances its Mt Mulgine project with a robust scoping study, revealing a globally significant multi-critical mineral deposit poised to meet soaring tungsten demand amid supply constraints.

LinQ Minerals reports consistent high-grade gold and copper mineralisation over a 300m strike at its Dam deposit, with further drilling planned to expand the resource.

Lefroy Exploration has begun mining ore at its Lucky Strike Gold Deposit, marking its transition to gold producer with first processing set for February 2026. This milestone aligns with strong gold prices, positioning Lefroy for potential cash flow generation.

Rent.com.au has achieved a record quarterly revenue exceeding $1 million, driven by strong recurring income from its RentBond® and RentPay products. This milestone underscores the company’s evolving business model and solid financial footing.

Cambium Bio has locked in a A$2.4 million strategic investment from Zheng Yang Biomedical Technology, reinforcing its push into pivotal Phase 3 trials for its dry eye disease treatment.

Golden State Mining Limited has appointed a new board and managing director, completed a $1.5 million capital raising, and is advancing exploration with a disciplined approach focused on its Western Australian gold projects.

Northern Star Resources has revised its FY26 all-in sustaining cost guidance upward following a downgrade in production forecasts and rising royalties, signaling tighter margins ahead.

Pioneer Minerals has validated primary tungsten mineralisation at its Springfield Prospect in Idaho, revealing high-grade scheelite and gold assays that underpin a promising multi-phase mineral system. The project’s proximity to established processing infrastructure offers strategic advantages for future development.

Pacific Edge reports a 13.4% decline in test volumes for Q3 2026 but gains strategic momentum with a key Medicare advisory meeting and clinical endorsements poised to influence reimbursement policy.

Summerset Group Holdings delivered a robust FY25 performance, achieving a 26% increase in total settlements driven by strong new sales and strategic expansion in Australia.